Soleus Capital Management, L.P. Lyra Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.12 - $7.51 $2.44 Million - $4.45 Million	592,417 New	592,417 $3.35 Million
Q1 2022 May 16, 2022	SELL	$3.5 - $5.36 $35,000 - $53,600	-10,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.22 - $9.41 $867,530 - $1.93 Million	-205,576 Reduced 95.36%	10,000 $44,000
Q3 2021 Nov 15, 2021	BUY	$6.06 - $9.43 $196,950 - $306,475	32,500 Added 17.75%	215,576 $1.97 Million
Q2 2021 Aug 16, 2021	SELL	$6.91 - $12.59 $2.02 Million - $3.69 Million	-292,738 Reduced 61.52%	183,076 $1.47 Million

Q1 2021 May 17, 2021	BUY	$10.38 - $15.61 $204,236 - $307,142	19,676 Added 4.31%	475,814 $5.52 Million
Q4 2020 Apr 29, 2021	BUY	$9.28 - $13.88 $3.55 Million - $5.3 Million	382,018 Added 515.4%	456,138 $5.2 Million
Q4 2020 Feb 16, 2021	SELL	$9.28 - $13.88 $339,184 - $507,314	-36,550 Reduced 33.03%	74,120 $845,000
Q3 2020 Nov 13, 2020	BUY	$10.61 - $13.96 $530,500 - $698,000	50,000 Added 82.41%	110,670 $1.24 Million
Q2 2020 Aug 14, 2020	BUY	$10.91 - $18.56 $661,909 - $1.13 Million	60,670 New	60,670 $687,000

44.4M

300K

1.3K

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $8.91M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.